YAP1 and squamous cell lung carcinoma: The findings suggest that YAP has a tumor-suppressor function through downregulating GPX2 expression in a DNp63-dependent manner, and more studies focus on the regulation of ROS by YAP are needed to improve precision medicine for the treatment of lung squamous cell carcinoma [104].